Expression and characterization of Escherichia coli derived hepatitis C virus ARFP/F protein
- 96 Downloads
Genome of the hepatitis C virus (HCV) contains a long open reading frame encoding a polyprotein that is cleaved into 10 proteins. Recently, a novel, so called “ARFP/F”, or “core+1,” protein, which is expressed through a ribosomal frame shift within the capsid-coding sequence, has been described. Herein, to produce and characterize a recombinant form of this protein, the DNA sequence corresponding to the ARFP/F protein (amino acid 11–161) was amplified using a frame-shifted forward primer exploiting the capsid sequence of the lb-subtype as a template. The amplicon was cloned into the pET-24a vector and expressed in different Escherichia coli strains. The expressed protein (mostly as insoluble inclusion bodies) was purified under denaturing conditions on a nickel-nitrilotriacetic acid (Ni-NTA) affinity column in a single step with a yield of 5 mg/L of culture media. After refolding steps, characterization of expressed ARFP/F was performed by SDS-PAGE and Western blot assay using specific antibodies. Antigenic properties of the protein were verified by ELISA using HCV-infected human sera and by its ability for a strong and specific interaction with sera of mice immunized with the peptide encoding a dominant ARFP/F B-cell epitope. The antigenicity plot revealed 3 major antigenic domains in the first half of the ARFP/F sequence. Immunization of BALB/c mice with the ARFP/F protein elicited high titers of IgG indicating the relevance of produced protein for induction of a humoral response. In conclusion, possibility of ARFP/F expression with a high yield and immunogenic potency of this protein in a mouse model have been demonstrated.
Keywordshepatitis C virus ARFP/F Core+1 expression immunization
Unable to display preview. Download preview PDF.
- 10.Walewski J., Keller T., Branch A. 1998. HCV patients have antibodies against a novel protein encoded in a second reading frame. Hepatology. 28, 278A.Google Scholar
- 17.Huang Y., Cheng J., Zhang S., Wang L., Guo J., Liu Y., Yang Y., Zhang L., Bai G., Gao X. 2005. Screening of hepatocyte proteins binding to F protein of hepatitis C virus by yeast two-hybrid system. World J. Gastroenterol. 11, 565956–565965.Google Scholar
- 22.Troesch M., Jalbert E., Canobio S., Boulassel M., Routy J., Bernard N., Bruneau J., Lapointe N., Boucher M., Soudeyns H. 2005. Characterization of humoral and cell-mediated immune responses directed against hepatitis C virus F protein in subjects coinfected with hepatitis C virus and HIV-1. AIDS. 19, 775–784.PubMedCrossRefGoogle Scholar
- 23.Bain C., Parroche P., Lavergne J., Duverger B., Vieux C., Dubois V., Komurian-Pradel F., Trepo C., Gebuhrer L., Paranhos Baccala G. 2004. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection. J. Virol. 78, 10460–10469.PubMedCrossRefGoogle Scholar
- 27.Sambrook J., Fritsch E.E., Maniatis T. 1989. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Lab. Press.Google Scholar
- 34.Goncharuk M.V., Schulga A.A., Ermolyuk Ya.S., Tkach E.N., Goncharuk S.A., Pustovalova Yu.E., Mineeva K.S., Bocharova E.V., Maslennikova I.V., Arseniev A.S., Kirpichnikov M.P. 2011. Bacterial synthesis, purification, and solubilization of transmembrane segments of ErbB family receptors. Mol. Biol. (Moscow). 45, 823–832.CrossRefGoogle Scholar
- 35.Pawlotsky J.M., Morice Y., Miladi A., Lavergne J.P., Germanidis G. 2005. Abstr. 12th Int.Conf. “Hepatitis C Virus and Related Viruses,” Montreal, Canada, 2005.Google Scholar
- 36.Zhang X.C.L., Fournillier A. 2004. Vaccine induced immune responses specific of the alternate reading frame protein (ARFP) of HCV. Abstr.11th Int.Conf. “Hepatitis C Virus and Related Viruses,” Heidelberg, Germany, 2004.Google Scholar